Nutraceutical COMP-4 confers protection against endothelial dysfunction through the eNOS/iNOS-NO-cGMP pathway.
The nutraceutical COMP-4 -consisting of L-citrulline, ginger extract, and herbal components Paullinia cupana and muira puama-has been shown previously to stimulate the production of nitric oxide (NO) in a variety of tissue types. We hypothesized that COMP-4 may have a protective, stimulatory effect...
Saved in:
Main Authors: | Monica G Ferrini, Andrea Abraham, Revecca Millán, Leslie Graciano, Sriram V Eleswarapu, Jacob Rajfer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0316798 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IL-4 induces cAMP and cGMP in human monocytic cells
by: B. Dugas, et al.
Published: (1995-01-01) -
iNOS Promotes the Development of Osteosarcoma via Wnt/β-Catenin Pathway
by: Wei Chu, et al.
Published: (2021-01-01) -
Mesenchymal Stem Cells Attenuate Cisplatin-Induced Nephrotoxicity in iNOS-Dependent Manner
by: Bojana Simovic Markovic, et al.
Published: (2017-01-01) -
Sildenafil (Viagra) Protective Effects on Neuroinflammation: The Role of iNOS/NO System in an Inflammatory Demyelination Model
by: Catarina Raposo, et al.
Published: (2013-01-01) -
Association of eNOS Gene Polymorphisms G894T and T-786C with Risk of Hepatorenal Syndrome
by: Yuksel Seckin, et al.
Published: (2016-01-01)